276 related articles for article (PubMed ID: 27830327)
21. FOXL2 mutation is absent in uterine tumors resembling ovarian sex cord tumors.
Chiang S; Staats PN; Senz J; Kommoss F; De Nictolis M; Huntsman DG; Gilks CB; Oliva E
Am J Surg Pathol; 2015 May; 39(5):618-23. PubMed ID: 25581731
[TBL] [Abstract][Full Text] [Related]
22. [Sex cord-stromal tumors of the ovary : Current aspects with a focus on granulosa cell tumors, Sertoli-Leydig cell tumors, and gynandroblastomas].
Kommoss F; Lehr HA
Pathologe; 2019 Feb; 40(1):61-72. PubMed ID: 30659330
[TBL] [Abstract][Full Text] [Related]
23. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry.
Schultz KA; Pacheco MC; Yang J; Williams GM; Messinger Y; Hill DA; Dehner LP; Priest JR
Gynecol Oncol; 2011 Aug; 122(2):246-50. PubMed ID: 21501861
[TBL] [Abstract][Full Text] [Related]
24. β-catenin (CTNNB1) S33C mutation in ovarian microcystic stromal tumors.
Maeda D; Shibahara J; Sakuma T; Isobe M; Teshima S; Mori M; Oda K; Nakagawa S; Taketani Y; Ishikawa S; Fukayama M
Am J Surg Pathol; 2011 Oct; 35(10):1429-40. PubMed ID: 21881488
[TBL] [Abstract][Full Text] [Related]
25. Germline mutations of DICER1 in Chinese women with BRCA1/BRCA2-negative familial breast cancer.
Cao WM; Gao Y; Yang HJ; Xie SN; Meng XL; Pan ZW; Chen ZH; Huang J; Ye WW; Shao XY; Wang XJ
Genet Mol Res; 2014 Dec; 13(4):10754-60. PubMed ID: 25526195
[TBL] [Abstract][Full Text] [Related]
26. Gynecologic Manifestations of the DICER1 Syndrome.
Stewart CJ; Charles A; Foulkes WD
Surg Pathol Clin; 2016 Jun; 9(2):227-41. PubMed ID: 27241106
[TBL] [Abstract][Full Text] [Related]
27. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
[TBL] [Abstract][Full Text] [Related]
28. Correlation of FOXL2 with Inhibin and Calretinin in the Diagnosis of Ovarian Sex Cord Stromal Tumors.
Rathore R; Arora D; Agarwal S; Sharma S
Turk Patoloji Derg; 2017; 33(2):121-128. PubMed ID: 28272677
[TBL] [Abstract][Full Text] [Related]
29. Expanding the morphological spectrum of ovarian microcystic stromal tumour.
McCluggage WG; Chong AS; Attygalle AD; Clarke BA; Chapman W; Rivera B; Foulkes WD
Histopathology; 2019 Feb; 74(3):443-451. PubMed ID: 30325056
[TBL] [Abstract][Full Text] [Related]
30. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features].
Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
[No Abstract] [Full Text] [Related]
31. DICER1 hot-spot mutations in ovarian gynandroblastoma.
Wang Y; Karnezis AN; Magrill J; Tessier-Cloutier B; Lum A; Senz J; Gilks CB; McCluggage WG; Huntsman DG; Kommoss F
Histopathology; 2018 Aug; 73(2):306-313. PubMed ID: 29660837
[TBL] [Abstract][Full Text] [Related]
32. Impact of a second opinion using expression and molecular analysis of FOXL2 for sex cord-stromal tumors. A study of the GINECO group & the TMRO network.
Maillet D; Goulvent T; Rimokh R; Vacher-Lavenu MC; Pautier P; Alexandre J; Pujade-Laurraine E; Devouassoux-Shisheboran M; Treilleux I; Ray-Coquard I; Savina A
Gynecol Oncol; 2014 Jan; 132(1):181-7. PubMed ID: 24157616
[TBL] [Abstract][Full Text] [Related]
33. Microcystic Stromal Tumor of the Ovary: A Case Report of a Newly Described Ovarian Neoplasm With a β-catenin (CTNNB1) G34E Mutation.
Podduturi V; Tran T; Champion KJ; Onur N; Shiller SM
Int J Gynecol Pathol; 2015 Nov; 34(6):541-5. PubMed ID: 26107566
[TBL] [Abstract][Full Text] [Related]
34. FOXL2 Mutation Analysis of Ovarian Sex Cord-Stromal Tumors: Genotype-Phenotype Correlation With Diagnostic Considerations.
Buza N; Wong S; Hui P
Int J Gynecol Pathol; 2018 Jul; 37(4):305-315. PubMed ID: 28700438
[TBL] [Abstract][Full Text] [Related]
35. Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs.
McCluggage WG; Rivera B; Chong AS; Clarke BA; Schultz KAP; Dehner LP; Tchrakian N; Apellaniz-Ruiz M; Gilks CB; Kommoss F; Stewart CJR; Foulkes WD
Am J Surg Pathol; 2023 Apr; 47(4):490-496. PubMed ID: 36583307
[TBL] [Abstract][Full Text] [Related]
36. Testicular Neoplasms With Sex Cord and Stromal Components Harbor a Recurrent Pattern of Chromosomal Gains.
Acosta AM; Sholl LM; Maclean F; Kao CS; Ulbright TM
Mod Pathol; 2024 Jan; 37(1):100368. PubMed ID: 37871653
[TBL] [Abstract][Full Text] [Related]
37. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
[TBL] [Abstract][Full Text] [Related]
38. Ovarian microcystic stromal tumor with undetermined potential: case study with molecular analysis and literature review.
Zhang Y; Tao L; Yin C; Wang W; Zou H; Ren Y; Liang W; Jiang J; Zhang W; Jia W; Li F
Hum Pathol; 2018 Aug; 78():171-176. PubMed ID: 29458068
[TBL] [Abstract][Full Text] [Related]
39. Detection of the DICER1 hotspot mutation alongside immunohistochemical analysis may provide a better diagnostic measure for ovarian Sertoli-Leydig cell tumors.
Zhang X; Shen D; Wang Y
Pathol Res Pract; 2018 Sep; 214(9):1370-1375. PubMed ID: 30072170
[TBL] [Abstract][Full Text] [Related]
40. Microcystic Stromal Tumor of Testicle: First Case Report and Literature Review.
Zhu P; Duan Y; Ao Q; Wang G
Cancer Res Treat; 2018 Oct; 50(4):1452-1457. PubMed ID: 29169232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
